Skip to main content
Attendees of Hitachi’s Users’ Meeting 2017
Tokyo, November 14, 2017 --- Hitachi welcomed leaders from its particle therapy centers around the world to its third Users' Meeting held in Tokyo on November 8th and 9th. Members from thirteen world-class particle therapy facilities in the United States, Japan, and Asia, as well as other regions which will have Hitachi's system in the future, joined the meeting to share their experiences with management, engineering teams and fellow users of Hitachi's systems.
Particle therapy is an advanced form of radiation therapy which offers less invasive treatments for cancer therapy compared to other forms of treatments such as surgery with minimal side effects allowing for even the elderly to undergo treatments and enabling faster rehabilitation. As a result, demand for particle therapy systems is increasing around the world. Since 2001, Hitachi has contracted leading hospitals in Japan, the United States, Asia and other regions with its particle therapy systems. Hitachi continues to partner with the world's most advanced treatment centers where over 16,000 patients have been treated to date with its systems and has established a reputation of high reliability with a proven track record.
Hitachi's Users' Meeting has been held since 2015 and is where the world's leading radiation oncologists, medical physicists and other medical professionals gather to share clinical experiences, opinions and requests regarding the system with Hitachi. Critical input from the last two Users' Meetings have helped refine new technologies and achieve shorter treatment times. These and other achievements will be used to further strengthen Hitachi’s R&D Roadmap, bringing clinical benefits to patients.
This year, participants from top-class facilities from around the world shared details of their facilities followed by a series of discussions regarding advanced techniques such as image-guided technology, motion management and advanced system maintenance. They also shared details of their treatments, providing those in attendance valuable clinical perspectives.
Hitachi will continue to strive to provide superior systems as a leader in particle therapy though future Users' Meetings and collaborative activities with users. Hitachi hopes to contribute to the medical community by providing solutions truly needed by users through high value and improving medical quality and efficacy through healthcare innovation.
This website includes information intended for healthcare professionals.
Please note that all descriptions in this website conform to the Pharmaceutical and Medical Device Act in Japan as well as other laws and regulations in Japan. Model names, specifications and configurations of products in overseas market outside Japan may be different by the countries.